Negativity on hot copper has absolutely nothing to do with the SP, that is down to performance and management.
A management that inherited a company with a share price of 1.82 and many lines of research that shareholders saw merit in, and took the company to 06Cents and maybe they are still not done.
The more research I do the more holes in Admedus appear. Adapt is not a product, its a process to turn a piece of animal tissue into a surgical patch. A process that was pioneered 15 to 20 years ago by Edwards Lifescience, their product is called Duravess. Medtronics an Indian company has also long ago perfected a patented process that comes up with a porcine pericardia surgical patch. their are many others that developed other processes in their forays into TAVR manufacture. In all my reading their are many inherent problems, tissue rejection, Toxic Shock, bleeding and infection being some of them, however Calcification has only ever been raised by Admedus, funny that. Just by way of interest both Edwards and Medtronics have been active in Australia for well over a decade, It seems we are one of the only countries in the world free of foot and mouth disease in our animal herds, Outbreaks in the US first occurred in 1870 and many times since, F&m is a viral disease and can be passed on to humans and can remain dormant is animal tissue. Europe has problems with BCE, so Australia is the source of most of the Animal tissue used in these surgical patches and scaffolds. Unfortunately time waits for no man. Patches and scaffolds are currently being grown in labs world wide, as well as being 3 D printed using a patients own living cells.DYOR but for those interested google "Heart research" and University of Tel aviv., Boston, Toronto, Melbourne, Monash, all with programmes, British Heart foundation Press release of June 2019. I could go on. but the best is ceders Sinai, as part of their genome research isolated the protein that turns ordinary stem cells into builder cells, Next step is to find the thing that tells the protein and stem cells that this is a heart, this is a liver this skin you guys need to build today. Already Rats bred with Heart defects have had Scaffolds 3D printed with rat cells fitted, and the protein introduce and the defects corrected and healed unaided. Similar results with rabbits were resulted in the British Heart Foundation research refered to above.
As for TAVR, Boston Scientific, Medtronics, and Edwards Lifescience are the world leaders, all FDA approved, I have found 19 manufacturers reviewed in medical journals, in the US and Europe, Admedus not one of them. of those awaiting approval the Jenna Valve is the standout, human trials of almost 400, and a 100% success rate, No breeding, no interventions, no infections or rejections. In the context of Admedus "Direct Flow Medical" is interesting reading. if you need more research you can look up "st judes Medical", "Merril life Science ", Accurate Neo" and" Allegra" all well established and all operating in the same space as Admedus.
It all gets down to Performance and Management, Not BS sales Hype. Facts not Fiction, and Integrity. All across Australia their are CEO and CFO's running Multi Million dollars companies, which Multi Million Dollar profits on an average salary of $15o to $240 K per annumm, all we get is accumulated Losses in excess $106 Million in 6 Years flogging out of date science.
AHZ Price at posting:
6.0¢ Sentiment: None Disclosure: Held
(20min delay)